Sbidian, E <br/><br/>
Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database.  [electronic resource] 

 -  The British journal of dermatology  03 2020 
 - 690-697 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.18047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>National Health Programs<br/>Psoriasis--drug therapy<br/>Thalidomide--analogs & derivatives